Atormac
brintellex
Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 2833  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

Diagnostic validity of the Ki-67 labeling index using the MIB-1 monoclonal antibody in the grading of meningiomas

Devaprasath A, Chacko G

Year : 2003| Volume: 51| Issue : 3 | Page no: 336-340

   This article has been cited by
 
1 Value of proliferation markers in the treatment of pituitary adenomas [Der Wert von Proliferationsmarkern bei der Behandlung von Hypophysenadenomen]
Widhalm, G. and Wolfsberger, S. and Knosp, E.
Journal fur Neurologie, Neurochirurgie und Psychiatrie. 2013; 13(4): 177-181
[Pubmed]  [Google Scholar]
2 Canine and feline intracranial meningiomas: An updated review
Motta, L. and Mandara, M.T. and Skerritt, G.C.
Veterinary Journal. 2012; 192(2): 153-165
[Pubmed]  [Google Scholar]
3 Detection of progesterone receptor and the correlation with Ki-67 labeling index in meningiomas
Mukherjee, S. and Ghosh, S.N. and Chatterjee, U. and Chatterjee, S.
Neurology India. 2011; 59(6): 817-822
[Pubmed]  [Google Scholar]
4 The clinical significance of MIB-1 labeling index in pituitary adenomas
Chacko, G. and Chacko, A.G. and Kovacs, K. and Scheithauer, B.W. and Mani, S. and Muliyil, J.P. and Seshadri, M.S.
Pituitary. 2010; 13(4): 337-344
[Pubmed]  [Google Scholar]
5 Does protein expression predict recurrence of benign World Health Organization grade I meningioma?
Kärjä, V., Sandell, P.-J., Kauppinen, T., Alafuzoff, I.
Human Pathology. 2010; 41(2): 1-2
[Pubmed]  [Google Scholar]
6 Characterization of morphologically benign biologically aggressive meningiomas
Rao, S., Sadiya, N., Doraiswami, S., Prathiba, D.
Neurology India. 2009; 57(6): 1-2
[Pubmed]  [Google Scholar]
7 Ki-67 and vascular endothelial growth factor expression in intracranial meningiomas in dogs
Matiasek, L.A., Platt, S.R., Adams, V., Scase, T.J., Keys, D., Miller, J., Adamo, F., (...), Matiasek, K.
Journal of Veterinary Internal Medicine. 2009; 23(1): 1-2
[Pubmed]  [Google Scholar]
8 Pathodiagnostic parameters for meningioma grading
Moradi, A., Semnani, V., Djam, H., Tajodini, A., Zali, A.R., Ghaemi, K., Nikzad, N., Madani-Civi, M.
Journal of Clinical Neuroscience. 2008; 15(12): 1-2
[Pubmed]  [Google Scholar]
9 MIB-1 immunolabeling: A valuable marker in prediction of benign recurring meningiomas
Vankalakunti, M., Vasishta, R.K., Radotra, B.D., Khosla, V.K.
Neuropathology. 2007; 27(5): 1-2
[Pubmed]  [Google Scholar]
10 Stereotactic radiation treatment for recurrent nonbenign meningiomas
Mattozo, C.A., De Salles, A.A.F., Klement, I.A., Gorgulho, A., McArthur, D., Ford, J.M., Agazaryan, N., (...), Selch, M.T.
Journal of Neurosurgery. 2007; 106(5): 846-854
[Pubmed]  [Google Scholar]
11 CDX-2 and MIB-1 expression in the colorectum: Correlation with morphological features of adenomatous lesions
Woodland, J.G.
British Journal of Biomedical Science. 2006; 63(2): 68-73
[Pubmed]  [Google Scholar]

 

Online since 20th March '04
Published by Wolters Kluwer - Medknow